Research

The research activities of the Hematology Section include both clinical and laboratory research. Details of research interests of each faculty are noted in their individual pages.

Current areas of laboratory research programs include immunobiology of plasma cell diseases (Madhav Dhodapkar), and cellular and molecular biology of blood cell production and hematopoiesis (Bernard Forget). The research activities are funded by the National Institutes of Health.

Areas of clinical research interest include leukemia (Peter Marks), mast cell disease (Thomas Duffy), myeloma and related plasma cell disorders (Dhodapkar), coagulopathies and non-malignant hematology (Peter McPhedran), sickle cell disease and palliative care (Lawrence Solomon). Other faculty affiliated with the section (Brian Smith, Harvey Rinder) also carry out basic and clinical research related to hematology. Research programs in hematologic malignancies are in close collaboration with colleagues in Leukemia, Lymphoma and Myeloma program at the Yale Cancer Center.

In addition to the individual research programs of primary faculty members of the Hematology Section, collaborative research projects are ongoing with faculty members of several other departments, such as Laboratory Medicine, Pathology, Immunobiology and Genetics, who have common research interests.